Nomura Instinet Upgrades Tata Motors to Neutral

Nomura Instinet analyst Kapil Singh upgrades Tata Motors (NYSE:TTM) from Reduce to Neutral.

byBenzinga Newsdesk

June 29, 2021

1 minute read

Nomura Instinet analyst Kapil Singh upgrades Tata Motors (NYSE:TTM) from Reduce to Neutral.

FDA
News

Moderna, Tabuk Pharma Report Partnership To Commercialize Moderna’s COVID-19 Vaccine In Saudi Arabia, No Terms Disclosed

By Benzinga Newsdesk

June 11, 8:31 AM

Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Tabuk Pharmaceutical Manufacturing Company (a fully owned subsidiary of Astra Industrial Group), a

MRNA

Idera Pharma Acquires Rare Disease Player, Names New CEO

By Vandana Singh

September 29, 9:52 AM

Idera Pharmaceuticals Inc (NASDAQ: IDRA) acquired Aceragen Inc, a privately-held biotechnology company focused on rare, orphan pulmonary, and rheumatic diseases.

IDRA

Del Taco Expands Southeast Footprint With First North Carolina Deal; To Open 5 Restaurants In North Carolina

By Benzinga Newsdesk

October 6, 9:07 AM

Del Taco Restaurants, Inc. (NASDAQ:TACO), the nation's second largest Mexican quick service restaurant*, has signed a deal with successful North Carolina-based franchise group, Ram Restaurants Inc.

TACO

Anheuser-Busch InBev Q4 Adj EPS $0.86 Beats $0.70 Estimate, Sales $14.67B Miss $15.37B Estimate

By Benzinga Newsdesk

March 2, 4:04 AM

Anheuser-Busch InBev (NYSE:BUD) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $0.70 by 22.86 percent. This is a 16.22 percent increase over earnings of $0.74 per share from

BUD

Nomura Instinet Upgrades Tata Motors to Neutral

Related Posts

Moderna, Tabuk Pharma Report Partnership To Commercialize Moderna’s COVID-19 Vaccine In Saudi Arabia, No Terms Disclosed

Idera Pharma Acquires Rare Disease Player, Names New CEO

Del Taco Expands Southeast Footprint With First North Carolina Deal; To Open 5 Restaurants In North Carolina

Anheuser-Busch InBev Q4 Adj EPS $0.86 Beats $0.70 Estimate, Sales $14.67B Miss $15.37B Estimate